Hainan Huluwa Pharmaceutical Group Co. Ltd.SSE: 605199

Announcement on Obtaining the Drug Registration Certificate for Ipratropium Bromide Solution for Inhalation

· Issued by Hainan Huluwa Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

The drug is classified as a chemical drug and is available in two specifications for treating respiratory conditions.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining the Drug Registration Certificate for Ipratropium Bromide Solution for Inhalation

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Hainan Huluwa Pharmaceutical Group Co. Ltd. on 6ix

Earlier from Hainan Huluwa Pharmaceutical

Later from Hainan Huluwa Pharmaceutical

All Hainan Huluwa Pharmaceutical news releases